API | l-alanine

l-alanine Report issue

Small molecule Experimental

AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW

Alanine is a non-essential aminoacid encoded by GCU, GCC, GCA, and GCG codons. Besides being a building block of proteins, alanine plays a key role in glucose-alanine cycle. Alanine is medically used as a dietary supplement for conditions such as fructose intolerance, muscle atrophy, low birth weight. ^NCATS

Chemistry

SMILES: C[C@H](N)C(O)=O
InChIKey: QNAYBMKLOCPYGJ-REOHCLBHSA-N
Mol. Mass: 89.0932
ALogP: -0.58 Partition coefficient
ChEMBL Molecules:

alanine

l-alanine

More Chemistry

Pharmacology

Mechanism of Action:
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

Organizations (22)

Research & Development (22)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (11)

Approved Indications (1)

Burns (approved 1971)

Experimental Indications - Clinical Trial Phases 1-4 (10)

Brain Neoplasms (Phase 1)

Cystic Fibrosis (Phase 2)

Fructose Intolerance ()

Immune System Diseases (Phase 2)

Infant, Low Birth Weight ()

Lung Neoplasms (Phase 2)

Mesothelioma, Malignant (Phase 2)

Muscular Atrophy ()

Pancreatic Neoplasms (Phase 2)

Sarcoma (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 14
# of Trial Organizations: 22

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue